Brokerages Set HealthStream, Inc. (NASDAQ:HSTM) Target Price at $31.50

HealthStream, Inc. (NASDAQ:HSTM) has earned a consensus rating of “Moderate Buy” from the five ratings firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $31.50.

Several equities analysts recently issued reports on HSTM shares. Barclays boosted their price objective on HealthStream from $32.00 to $34.00 and gave the company an “overweight” rating in a research report on Wednesday, October 23rd. Canaccord Genuity Group upped their price target on HealthStream from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. StockNews.com downgraded HealthStream from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. Finally, Craig Hallum raised HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th.

HealthStream Price Performance

Shares of HSTM stock opened at $29.33 on Friday. The stock has a market cap of $892.22 million, a PE ratio of 45.12, a price-to-earnings-growth ratio of 3.89 and a beta of 0.35. The stock has a 50-day moving average of $28.80 and a 200-day moving average of $28.08. HealthStream has a one year low of $23.92 and a one year high of $31.15.

HealthStream (NASDAQ:HSTM) last issued its quarterly earnings data on Monday, October 21st. The technology company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.06. HealthStream had a return on equity of 5.67% and a net margin of 6.84%. The business had revenue of $73.10 million during the quarter, compared to analyst estimates of $73.53 million. During the same period in the previous year, the firm earned $0.13 EPS. HealthStream’s quarterly revenue was up 4.0% compared to the same quarter last year. As a group, research analysts anticipate that HealthStream will post 0.63 earnings per share for the current year.

HealthStream Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be issued a $0.028 dividend. This represents a $0.11 annualized dividend and a dividend yield of 0.38%. The ex-dividend date of this dividend is Monday, November 4th. HealthStream’s payout ratio is presently 16.92%.

Insider Activity

In other news, SVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now owns 9,527 shares of the company’s stock, valued at approximately $267,041.81. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, SVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the completion of the sale, the senior vice president now owns 9,527 shares of the company’s stock, valued at approximately $267,041.81. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 20.60% of the stock is currently owned by insiders.

Institutional Investors Weigh In On HealthStream

A number of large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its stake in HealthStream by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 2,938,685 shares of the technology company’s stock valued at $78,345,000 after acquiring an additional 31,943 shares during the period. Dimensional Fund Advisors LP increased its position in HealthStream by 1.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,570,735 shares of the technology company’s stock worth $43,824,000 after buying an additional 15,379 shares during the period. First Eagle Investment Management LLC increased its position in HealthStream by 7.1% during the 2nd quarter. First Eagle Investment Management LLC now owns 530,178 shares of the technology company’s stock worth $14,792,000 after buying an additional 35,350 shares during the period. Harbor Capital Advisors Inc. increased its position in HealthStream by 141.2% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 400,033 shares of the technology company’s stock worth $11,537,000 after buying an additional 234,148 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in HealthStream by 37.3% during the 3rd quarter. Assenagon Asset Management S.A. now owns 201,601 shares of the technology company’s stock worth $5,814,000 after buying an additional 54,775 shares during the period. Institutional investors own 69.58% of the company’s stock.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.